ONKURE THERAPEUTICS Insider Manke Isaac Executes Massive 300,000‑Share Option, Quickly Sells 15,300 Shares in Rapid Profit‑Taking Move.
Onkur Therapeutics insider activity: Manke Isaac’s recent option grant and sale reveal a strategic, confidence‑driven approach—watch the stock’s short‑term moves for long‑term insight.
3 minutes to read
